APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decentralized Clinical Trial Platforms

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Decentralized Clinical Trial Platforms Market Outlook and Growth Opportunities 2026

3 March 2026216 pages

Choose your research edition.

Industry ResearchDecentralized Clinical Trial Platforms Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Decentralized Clinical Trial Platforms Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Decentralized Clinical Trial Platforms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decentralized Clinical Trial Platforms Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Decentralized Clinical Trial Platforms Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Decentralized Clinical Trial Platforms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decentralized Clinical Trial Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Decentralized Clinical Trial Platforms market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Decentralized Clinical Trial Platforms market include Medidata, IQVIA, Veeva Systems, Castor, Delve Health, Jeeva, Signant Health, Clinical Ink and ObvioHealth, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Decentralized Clinical Trial Platforms market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Decentralized Clinical Trial Platforms and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Decentralized Clinical Trial Platforms revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Decentralized Clinical Trial Platforms market.

Decentralized Clinical Trial Platforms Segment by Company

Medidata

IQVIA

Veeva Systems

Castor

Delve Health

Jeeva

Signant Health

Clinical Ink

ObvioHealth

THREAD

Science 37

Medable, Clario

Aparito

Viedoc Technologies

Crucial Data Solutions

Medrio

Alira Health

Fortrea

Huma

Cliniv Health Tech

Datacubed Health

Decentralized Clinical Trial Platforms Segment by Type

Cloud Based

Web Based

Decentralized Clinical Trial Platforms Segment by Application

Pharmaceutical Companies

Biotechnology Firms

Contract Research Organizations (CROs)

Healthcare Institutions

Decentralized Clinical Trial Platforms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Decentralized Clinical Trial Platforms status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Decentralized Clinical Trial Platforms key companies, revenue, market share, and recent developments.

3. To split the Decentralized Clinical Trial Platforms breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Decentralized Clinical Trial Platforms market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Decentralized Clinical Trial Platforms significant trends, drivers, influence factors in global and regions.

6. To analyze Decentralized Clinical Trial Platforms competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decentralized Clinical Trial Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decentralized Clinical Trial Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decentralized Clinical Trial Platforms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Decentralized Clinical Trial Platforms industry.

Chapter 3: Detailed analysis of Decentralized Clinical Trial Platforms company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Decentralized Clinical Trial Platforms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Decentralized Clinical Trial Platforms in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Decentralized Clinical Trial Platforms Industry Trends Table 2. Decentralized Clinical Trial Platforms Industry Drivers Table 3. Decentralized Clinical Trial Platforms Industry Opportunities and Challenges Table 4. Decentralized Clinical Trial Platforms Industry Restraints Table 5. Global Decentralized Clinical Trial Platforms Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Decentralized Clinical Trial Platforms Revenue Share by Company (2021-2026) Table 7. Global Decentralized Clinical Trial Platforms Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Decentralized Clinical Trial Platforms Key Company Manufacturing Base & Headquarters Table 9. Global Decentralized Clinical Trial Platforms Company, Product Type & Application Table 10. Global Decentralized Clinical Trial Platforms Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Decentralized Clinical Trial Platforms by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud Based Table 15. Significant Companies of Web Based Table 16. Global Decentralized Clinical Trial Platforms Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Decentralized Clinical Trial Platforms Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Decentralized Clinical Trial Platforms Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Decentralized Clinical Trial Platforms Sales Value Share by Type (2021-2026) Table 20. Global Decentralized Clinical Trial Platforms Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Companies Table 22. Significant Companies of Biotechnology Firms Table 23. Significant Companies of Contract Research Organizations (CROs) Table 24. Significant Companies of Healthcare Institutions Table 25. Global Decentralized Clinical Trial Platforms Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Decentralized Clinical Trial Platforms Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Decentralized Clinical Trial Platforms Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Decentralized Clinical Trial Platforms Sales Value Share by Application (2021-2026) Table 29. Global Decentralized Clinical Trial Platforms Sales Value Share by Application (2027-2032) Table 30. Global Decentralized Clinical Trial Platforms Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Decentralized Clinical Trial Platforms Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Decentralized Clinical Trial Platforms Sales Value Share by Region (2021-2026) Table 33. Global Decentralized Clinical Trial Platforms Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Decentralized Clinical Trial Platforms Sales Value Share by Region (2027-2032) Table 35. Global Decentralized Clinical Trial Platforms Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Decentralized Clinical Trial Platforms Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Decentralized Clinical Trial Platforms Sales Value Market Share by Country (2021-2026) Table 38. Global Decentralized Clinical Trial Platforms Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Decentralized Clinical Trial Platforms Sales Value Market Share by Country (2027-2032) Table 40. Medidata Company Information Table 41. Medidata Business Overview Table 42. Medidata Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Medidata Decentralized Clinical Trial Platforms Product Portfolio Table 44. Medidata Recent Development Table 45. IQVIA Company Information Table 46. IQVIA Business Overview Table 47. IQVIA Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. IQVIA Decentralized Clinical Trial Platforms Product Portfolio Table 49. IQVIA Recent Development Table 50. Veeva Systems Company Information Table 51. Veeva Systems Business Overview Table 52. Veeva Systems Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Veeva Systems Decentralized Clinical Trial Platforms Product Portfolio Table 54. Veeva Systems Recent Development Table 55. Castor Company Information Table 56. Castor Business Overview Table 57. Castor Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Castor Decentralized Clinical Trial Platforms Product Portfolio Table 59. Castor Recent Development Table 60. Delve Health Company Information Table 61. Delve Health Business Overview Table 62. Delve Health Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Delve Health Decentralized Clinical Trial Platforms Product Portfolio Table 64. Delve Health Recent Development Table 65. Jeeva Company Information Table 66. Jeeva Business Overview Table 67. Jeeva Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Jeeva Decentralized Clinical Trial Platforms Product Portfolio Table 69. Jeeva Recent Development Table 70. Signant Health Company Information Table 71. Signant Health Business Overview Table 72. Signant Health Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Signant Health Decentralized Clinical Trial Platforms Product Portfolio Table 74. Signant Health Recent Development Table 75. Clinical Ink Company Information Table 76. Clinical Ink Business Overview Table 77. Clinical Ink Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Clinical Ink Decentralized Clinical Trial Platforms Product Portfolio Table 79. Clinical Ink Recent Development Table 80. ObvioHealth Company Information Table 81. ObvioHealth Business Overview Table 82. ObvioHealth Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. ObvioHealth Decentralized Clinical Trial Platforms Product Portfolio Table 84. ObvioHealth Recent Development Table 85. THREAD Company Information Table 86. THREAD Business Overview Table 87. THREAD Decentralized Clinical Trial Platforms Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. THREAD Decentralized Clinical Trial Platforms Product Portfolio Table 89. THREAD Recent Development Table 90. Science 37 Company Information Table 91. Science 37 Business Overview Table 92. Science 37 Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Science 37 Decentralized Clinical Trial Platforms Product Portfolio Table 94. Science 37 Recent Development Table 95. Medable, Clario Company Information Table 96. Medable, Clario Business Overview Table 97. Medable, Clario Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Medable, Clario Decentralized Clinical Trial Platforms Product Portfolio Table 99. Medable, Clario Recent Development Table 100. Aparito Company Information Table 101. Aparito Business Overview Table 102. Aparito Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Aparito Decentralized Clinical Trial Platforms Product Portfolio Table 104. Aparito Recent Development Table 105. Viedoc Technologies Company Information Table 106. Viedoc Technologies Business Overview Table 107. Viedoc Technologies Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Viedoc Technologies Decentralized Clinical Trial Platforms Product Portfolio Table 109. Viedoc Technologies Recent Development Table 110. Crucial Data Solutions Company Information Table 111. Crucial Data Solutions Business Overview Table 112. Crucial Data Solutions Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Crucial Data Solutions Decentralized Clinical Trial Platforms Product Portfolio Table 114. Crucial Data Solutions Recent Development Table 115. Medrio Company Information Table 116. Medrio Business Overview Table 117. Medrio Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Medrio Decentralized Clinical Trial Platforms Product Portfolio Table 119. Medrio Recent Development Table 120. Alira Health Company Information Table 121. Alira Health Business Overview Table 122. Alira Health Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Alira Health Decentralized Clinical Trial Platforms Product Portfolio Table 124. Alira Health Recent Development Table 125. Fortrea Company Information Table 126. Fortrea Business Overview Table 127. Fortrea Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Fortrea Decentralized Clinical Trial Platforms Product Portfolio Table 129. Fortrea Recent Development Table 130. Huma Company Information Table 131. Huma Business Overview Table 132. Huma Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Huma Decentralized Clinical Trial Platforms Product Portfolio Table 134. Huma Recent Development Table 135. Cliniv Health Tech Company Information Table 136. Cliniv Health Tech Business Overview Table 137. Cliniv Health Tech Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Cliniv Health Tech Decentralized Clinical Trial Platforms Product Portfolio Table 139. Cliniv Health Tech Recent Development Table 140. Datacubed Health Company Information Table 141. Datacubed Health Business Overview Table 142. Datacubed Health Decentralized Clinical Trial Platforms Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Datacubed Health Decentralized Clinical Trial Platforms Product Portfolio Table 144. Datacubed Health Recent Development Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Decentralized Clinical Trial Platforms Product Image Figure 2. Global Decentralized Clinical Trial Platforms Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decentralized Clinical Trial Platforms Market Size (2021-2032) & (US$ Million) Figure 4. Global Decentralized Clinical Trial Platforms Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud Based Image Figure 8. Web Based Image Figure 9. Global Decentralized Clinical Trial Platforms Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Decentralized Clinical Trial Platforms Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Decentralized Clinical Trial Platforms Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Companies Image Figure 13. Biotechnology Firms Image Figure 14. Contract Research Organizations (CROs) Image Figure 15. Healthcare Institutions Image Figure 16. Global Decentralized Clinical Trial Platforms Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Decentralized Clinical Trial Platforms Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Decentralized Clinical Trial Platforms Sales Value Share by Application (2021-2032) Figure 19. Global Decentralized Clinical Trial Platforms Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Decentralized Clinical Trial Platforms Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Decentralized Clinical Trial Platforms Sales Value (2021-2032) & (US$ Million) Figure 22. North America Decentralized Clinical Trial Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Decentralized Clinical Trial Platforms Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Decentralized Clinical Trial Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Decentralized Clinical Trial Platforms Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Decentralized Clinical Trial Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Decentralized Clinical Trial Platforms Sales Value (2021-2032) & (US$ Million) Figure 28. South America Decentralized Clinical Trial Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Decentralized Clinical Trial Platforms Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Decentralized Clinical Trial Platforms Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • Web Based
Applications
  • Pharmaceutical Companies
  • Biotechnology Firms
  • Contract Research Organizations (CROs)
  • Healthcare Institutions
Companies covered
  • Medidata
  • IQVIA
  • Veeva Systems
  • Castor
  • Delve Health
  • Jeeva
  • Signant Health
  • Clinical Ink
  • ObvioHealth
  • THREAD
  • Science 37
  • Medable, Clario
  • Aparito
  • Viedoc Technologies
  • Crucial Data Solutions
  • Medrio
  • Alira Health
  • Fortrea
  • Huma
  • Cliniv Health Tech
  • Datacubed Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Decentralized Clinical Trial Platforms Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Decentralized Clinical Trial Platforms Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Decentralized Clinical Trial Platforms Market Dynamics
  1. 2.1 Decentralized Clinical Trial Platforms Industry Trends
  2. 2.2 Decentralized Clinical Trial Platforms Industry Drivers
  3. 2.3 Decentralized Clinical Trial Platforms Industry Opportunities and Challenges
  4. 2.4 Decentralized Clinical Trial Platforms Industry Restraints
3 Decentralized Clinical Trial Platforms Market by Company
  1. 3.1 Global Decentralized Clinical Trial Platforms Company Revenue Ranking in 2025
  2. 3.2 Global Decentralized Clinical Trial Platforms Revenue by Company (2021-2026)
  3. 3.3 Global Decentralized Clinical Trial Platforms Company Ranking (2024-2026)
  4. 3.4 Global Decentralized Clinical Trial Platforms Company Manufacturing Base and Headquarters
  5. 3.5 Global Decentralized Clinical Trial Platforms Company Product Type and Application
  6. 3.6 Global Decentralized Clinical Trial Platforms Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Decentralized Clinical Trial Platforms Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Decentralized Clinical Trial Platforms Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Decentralized Clinical Trial Platforms Market by Type
  1. 4.1 Decentralized Clinical Trial Platforms Type Introduction
  2. 4.1.1 Cloud Based
  3. 4.1.2 Web Based
  4. 4.2 Global Decentralized Clinical Trial Platforms Sales Value by Type
  5. 4.2.1 Global Decentralized Clinical Trial Platforms Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Decentralized Clinical Trial Platforms Sales Value by Type (2021-2032)
  7. 4.2.3 Global Decentralized Clinical Trial Platforms Sales Value Share by Type (2021-2032)
5 Decentralized Clinical Trial Platforms Market by Application
  1. 5.1 Decentralized Clinical Trial Platforms Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Biotechnology Firms
  4. 5.1.3 Contract Research Organizations (CROs)
  5. 5.1.4 Healthcare Institutions
  6. 5.2 Global Decentralized Clinical Trial Platforms Sales Value by Application
  7. 5.2.1 Global Decentralized Clinical Trial Platforms Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Decentralized Clinical Trial Platforms Sales Value by Application (2021-2032)
  9. 5.2.3 Global Decentralized Clinical Trial Platforms Sales Value Share by Application (2021-2032)
6 Decentralized Clinical Trial Platforms Regional Value Analysis
  1. 6.1 Global Decentralized Clinical Trial Platforms Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Decentralized Clinical Trial Platforms Sales Value by Region (2021-2032)
  3. 6.2.1 Global Decentralized Clinical Trial Platforms Sales Value by Region: 2021-2026
  4. 6.2.2 Global Decentralized Clinical Trial Platforms Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Decentralized Clinical Trial Platforms Sales Value (2021-2032)
  7. 6.3.2 North America Decentralized Clinical Trial Platforms Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Decentralized Clinical Trial Platforms Sales Value (2021-2032)
  10. 6.4.2 Europe Decentralized Clinical Trial Platforms Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Decentralized Clinical Trial Platforms Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Decentralized Clinical Trial Platforms Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Decentralized Clinical Trial Platforms Sales Value (2021-2032)
  16. 6.6.2 South America Decentralized Clinical Trial Platforms Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Decentralized Clinical Trial Platforms Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Decentralized Clinical Trial Platforms Sales Value Share by Country, 2025 VS 2032
7 Decentralized Clinical Trial Platforms Country-level Value Analysis
  1. 7.1 Global Decentralized Clinical Trial Platforms Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Decentralized Clinical Trial Platforms Sales Value by Country (2021-2032)
  3. 7.2.1 Global Decentralized Clinical Trial Platforms Sales Value by Country (2021-2026)
  4. 7.2.2 Global Decentralized Clinical Trial Platforms Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Decentralized Clinical Trial Platforms Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Decentralized Clinical Trial Platforms Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Decentralized Clinical Trial Platforms Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medidata
  2. 8.1.1 Medidata Company Information
  3. 8.1.2 Medidata Business Overview
  4. 8.1.3 Medidata Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medidata Decentralized Clinical Trial Platforms Product Portfolio
  6. 8.1.5 Medidata Recent Developments
  7. 8.2 IQVIA
  8. 8.2.1 IQVIA Company Information
  9. 8.2.2 IQVIA Business Overview
  10. 8.2.3 IQVIA Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IQVIA Decentralized Clinical Trial Platforms Product Portfolio
  12. 8.2.5 IQVIA Recent Developments
  13. 8.3 Veeva Systems
  14. 8.3.1 Veeva Systems Company Information
  15. 8.3.2 Veeva Systems Business Overview
  16. 8.3.3 Veeva Systems Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Veeva Systems Decentralized Clinical Trial Platforms Product Portfolio
  18. 8.3.5 Veeva Systems Recent Developments
  19. 8.4 Castor
  20. 8.4.1 Castor Company Information
  21. 8.4.2 Castor Business Overview
  22. 8.4.3 Castor Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Castor Decentralized Clinical Trial Platforms Product Portfolio
  24. 8.4.5 Castor Recent Developments
  25. 8.5 Delve Health
  26. 8.5.1 Delve Health Company Information
  27. 8.5.2 Delve Health Business Overview
  28. 8.5.3 Delve Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Delve Health Decentralized Clinical Trial Platforms Product Portfolio
  30. 8.5.5 Delve Health Recent Developments
  31. 8.6 Jeeva
  32. 8.6.1 Jeeva Company Information
  33. 8.6.2 Jeeva Business Overview
  34. 8.6.3 Jeeva Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jeeva Decentralized Clinical Trial Platforms Product Portfolio
  36. 8.6.5 Jeeva Recent Developments
  37. 8.7 Signant Health
  38. 8.7.1 Signant Health Company Information
  39. 8.7.2 Signant Health Business Overview
  40. 8.7.3 Signant Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Signant Health Decentralized Clinical Trial Platforms Product Portfolio
  42. 8.7.5 Signant Health Recent Developments
  43. 8.8 Clinical Ink
  44. 8.8.1 Clinical Ink Company Information
  45. 8.8.2 Clinical Ink Business Overview
  46. 8.8.3 Clinical Ink Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Clinical Ink Decentralized Clinical Trial Platforms Product Portfolio
  48. 8.8.5 Clinical Ink Recent Developments
  49. 8.9 ObvioHealth
  50. 8.9.1 ObvioHealth Company Information
  51. 8.9.2 ObvioHealth Business Overview
  52. 8.9.3 ObvioHealth Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ObvioHealth Decentralized Clinical Trial Platforms Product Portfolio
  54. 8.9.5 ObvioHealth Recent Developments
  55. 8.10 THREAD
  56. 8.10.1 THREAD Company Information
  57. 8.10.2 THREAD Business Overview
  58. 8.10.3 THREAD Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  59. 8.10.4 THREAD Decentralized Clinical Trial Platforms Product Portfolio
  60. 8.10.5 THREAD Recent Developments
  61. 8.11 Science 37
  62. 8.11.1 Science 37 Company Information
  63. 8.11.2 Science 37 Business Overview
  64. 8.11.3 Science 37 Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Science 37 Decentralized Clinical Trial Platforms Product Portfolio
  66. 8.11.5 Science 37 Recent Developments
  67. 8.12 Medable, Clario
  68. 8.12.1 Medable, Clario Company Information
  69. 8.12.2 Medable, Clario Business Overview
  70. 8.12.3 Medable, Clario Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Medable, Clario Decentralized Clinical Trial Platforms Product Portfolio
  72. 8.12.5 Medable, Clario Recent Developments
  73. 8.13 Aparito
  74. 8.13.1 Aparito Company Information
  75. 8.13.2 Aparito Business Overview
  76. 8.13.3 Aparito Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Aparito Decentralized Clinical Trial Platforms Product Portfolio
  78. 8.13.5 Aparito Recent Developments
  79. 8.14 Viedoc Technologies
  80. 8.14.1 Viedoc Technologies Company Information
  81. 8.14.2 Viedoc Technologies Business Overview
  82. 8.14.3 Viedoc Technologies Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Viedoc Technologies Decentralized Clinical Trial Platforms Product Portfolio
  84. 8.14.5 Viedoc Technologies Recent Developments
  85. 8.15 Crucial Data Solutions
  86. 8.15.1 Crucial Data Solutions Company Information
  87. 8.15.2 Crucial Data Solutions Business Overview
  88. 8.15.3 Crucial Data Solutions Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Crucial Data Solutions Decentralized Clinical Trial Platforms Product Portfolio
  90. 8.15.5 Crucial Data Solutions Recent Developments
  91. 8.16 Medrio
  92. 8.16.1 Medrio Company Information
  93. 8.16.2 Medrio Business Overview
  94. 8.16.3 Medrio Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Medrio Decentralized Clinical Trial Platforms Product Portfolio
  96. 8.16.5 Medrio Recent Developments
  97. 8.17 Alira Health
  98. 8.17.1 Alira Health Company Information
  99. 8.17.2 Alira Health Business Overview
  100. 8.17.3 Alira Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Alira Health Decentralized Clinical Trial Platforms Product Portfolio
  102. 8.17.5 Alira Health Recent Developments
  103. 8.18 Fortrea
  104. 8.18.1 Fortrea Company Information
  105. 8.18.2 Fortrea Business Overview
  106. 8.18.3 Fortrea Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Fortrea Decentralized Clinical Trial Platforms Product Portfolio
  108. 8.18.5 Fortrea Recent Developments
  109. 8.19 Huma
  110. 8.19.1 Huma Company Information
  111. 8.19.2 Huma Business Overview
  112. 8.19.3 Huma Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Huma Decentralized Clinical Trial Platforms Product Portfolio
  114. 8.19.5 Huma Recent Developments
  115. 8.20 Cliniv Health Tech
  116. 8.20.1 Cliniv Health Tech Company Information
  117. 8.20.2 Cliniv Health Tech Business Overview
  118. 8.20.3 Cliniv Health Tech Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Cliniv Health Tech Decentralized Clinical Trial Platforms Product Portfolio
  120. 8.20.5 Cliniv Health Tech Recent Developments
  121. 8.21 Datacubed Health
  122. 8.21.1 Datacubed Health Company Information
  123. 8.21.2 Datacubed Health Business Overview
  124. 8.21.3 Datacubed Health Decentralized Clinical Trial Platforms Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Datacubed Health Decentralized Clinical Trial Platforms Product Portfolio
  126. 8.21.5 Datacubed Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst